Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

NCT07642960 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Corneal Neovascularisation

Interventions

PROCEDURE: Fine-needle diathermy
DRUG: Bevacizumab

Sponsor

HoChiMinh City Eye Hospital